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ABSTRACT 
 
One of the most popular concepts currently is the use of stem cells in the regenerative 
therapy which replaces the lost or dysfunctional part in a human body. In order for a patient 
to benefit from such therapies, the stem cell source should be always made available. 
Therefore, it is important to preserve these cells so that they are always available for 
treatments. Cryopreservation is one of the important methods to preserve cells and tissues 
where it can be used for the recovery of damaged tissues and organs. Cryopreservation of 
stem cells is mainly to minimize any form of damage to biological materials at very low 
temperatures while freezing and also during storage. This issue can be addressed with the 
addition of a cryoprotective agent. Dimethyl sulfoxide (DMSO) is a common 
cryoprotective agent which is a polar compound originally created for the use as a solvent. 
However the use of DMSO may result in the toxicity of cells. The bird’s nest or also known 
as edible bird’s nest (EBN) is a health food with many traditional medicinal properties. 
Therefore, the objectives of this study are to evaluate the efficiency of EBN to act as a 
cryoprotective agent, to evaluate the differentiation ability to express the following 
lineages; osteogenic, adipogenic and chondrogenic after cryopreservation with the 
respective cryoprotectants (10% DMSO+90% FBS, 5% DMSO+1% EBN+94% FBS and 
1% EBN+99% FBS) and to evaluate the proliferative rate of the cryopreserved human 
adipose derived stem cells with the respective cryoprotectants (10% DMSO+90% FBS, 5% 
DMSO+1% EBN+94% FBS and 1% EBN+99% FBS). This study is designed to evaluate 
the ability of EBN to either act as a cryoprotectant to substitute DMSO or to act as a 
supplement to DMSO. The human adipose tissue were collected from the PPUM was 
isolated and cultured up to second passage. Then, the cells were cryopreserved in the 
 
 
respective cryoprotectant; 10% DMSO+90% FBS (Control), 5% DMSO+1% EBN+94% 
FBS and 1% EBN+99% FBS for a month. After a month, the cells were thawed and 
cultured for the following tests; cell viability test, resazurin test and differentiation into 
three lineages (adipogenic, chondrogenic and osteogenic). Then, the differentiated lineages 
were stained and the respective surface areas were determined. It can be concluded that the 
human adipose derived stem cells preserved in 10% DMSO+99%FBS had exhibited a 
higher result as compared to cells preserved in 5% DMSO+1% EBN+94%FBS and 1% 
EBN+99% FBS. Hence making DMSO still a good and superior cryoprotective agent. 
DMSO on its own can support the growth of the cells which can be seen in 10% 
DMSO+99% FBS and does not require the presence of EBN. Therefore, it can be 
concluded that EBN cannot act as a cryoprotective agent. EBN is better to be used in in 
vitro cell culture experiments instead of it as a cryoprotective agent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRAK 
 
Salah satu konsep yang paling popular pada masa ini ialah penggunaan sel stem dalam 
terapi regeneratif yang menggantikan bahagian yang hilang atau tidak berfungsi dalam 
badan manusia. Sumber sel stem harus sentiasa disediakan supaya pesakit dapat memanfaat 
daripada terapi ini. Oleh itu, adalah penting untuk memelihara sel-sel ini supaya ia sentiasa 
disediakan untuk rawatan. Krioawetan merupakan salah satu kaedah penting untuk 
memelihara sel dan tisu di mana ia boleh digunakan untuk pemulihan tisu dan organ yang 
rosak. Krioawetan sel stem adalah penting terutamanya untuk mengurangkan sebarang 
bentuk kerosakan pada bahan biologi pada suhu yang rendah ketika proses pembekuan dan 
penyimpanan. Isu ini boleh ditangani dengan penambahan agen cryoprotektif. Dimetil 
sulfoksida (DMSO) adalah ejen krioprotektif yang biasa digunakan, asalnya ia dicipta 
untuk digunakan sebagai pelarut. Walau bagaimanapun, penggunaan DMSO boleh 
menyebabkan ketoksikan sel. Sarang burung (EBN) adalah makanan kesihatan dengan 
pelbagai ciri-ciri perubatan tradisional. Oleh itu, objektif kajian ini adalah untuk menilai 
kecekapan EBN untuk bertindak sebagai ejen krioprotektif, bagi menilai kemampuan 
pembezaan untuk menyatakan keturunan berikut; adipogenik, osteogenik, dan kondrogenik 
setelah dikrioawet dengan krioprotektif masing-masing (10 % DMSO+90 % FBS, 5 % 
DMSO+1 % EBN+94 % FBS dan 1 % EBN+99 % FBS) dan juga untuk menilai kadar 
proliferative sel stem yang dikrioawet dengan krioprotektif masing-masing (10 % 
DMSO+90 % FBS, 5 % DMSO+1 % EBN+94 % FBS dan 1 % EBN+99 % FBS). Kajian 
ini bertujuan untuk menilai keupayaan EBN sama ada bertindak sebagai ejen krioprotektif 
untuk menggantikan DMSO atau untuk bertindak sebagai tambahan kepada DMSO. Tisu 
lemak yang dikumpul daripada PPUM telah diasingkan dan diternak sehingga laluan kedua. 
 
 
Kemudian, sel dikrioawet dalam krioprotektif masing-masing selama sebulan; 10 % 
DMSO+90 % FBS (Kawalan), 5 % DMSO+1 % EBN+94 % FBS dan 1 % EBN+99 % 
FBS. Selepas sebulan, sel telah dicairkan dan dikembangkan untuk ujian berikut; sel ujian 
daya maju, ujian resazurin dan pembezaan kepada tiga keturunan 
(adipogenik, osteogenik, dan kondrogenik). Sel yang dibezakan telah dinoda dan kawasan 
permukaan masing-masing telah ditentukan. Kesimpulannya adalah sel stem yang 
diperolehi daripada tisu lemak manusia yang dikrioawet dalam 10 % DMSO + 99 % FBS 
telah memaparkan hasil yang lebih tinggi berbanding dengan sel-sel yang dikrioawet dalam 
5 % DMSO + 1 % EBN + 94 % FBS dan 1 % EBN + 99 % FBS. Maka, boleh disimpulkan 
bahawa DMSO adalah ejen krioprotektif yang baik dan unggul. DMSO juga boleh 
menyokong pertumbuhan sel-sel tanpa memerlukan kehadiran EBN seperti yang dilihat 
dalam 10 % DMSO + 99 % FBS. Oleh itu, boleh disimpulkan bahawa EBN tidak boleh 
bertindak sebagai ejen krioprotektif dan ia adalah lebih baik untuk digunakan dalam 
eksperimen in vitro dan bukannya sebagai ejen krioprotektif. 
 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT 
 
Finally, I have completed my final year research report. Many people were involved 
throughout this research. First of all I would like to express my greatest gratitude to my 
supervisor, Dr. Wan Safwani Wan Kamarul Zaman for her guidance, assistance, patience 
and tolerance throughout the whole process of completing this research report. I would like 
to further thank my supervisor for her assistance, support and contribution of ideas. I am 
also grateful to Prof. Dr. Saad Mekhilef for his guidance on the research report writing in 
his research and methodology lectures and not to forget other University Malaya lecturers 
in Faculty of Biomedical Engineering for their knowledge and effort to guide me 
throughout my research report writing. 
Besides that, I would like to express my special gratitude to the lab assistant in 
tissue engineering laboratory, Miss Liyana Binti Abu as well as the PhD students in lab 
who deserve my warmest appreciation for their cooperation and teamwork in order to 
execute certain procedures in the laboratory and during thesis writing. Furthermore, I would 
like to thank few of my other course mates who helped me a lot during my laboratory work 
and research report writing. Wishing all of them the very best.  
Finally, I wish to acknowledge my deepest gratitude to my beloved parents, Mr. 
Vaithianathan and Madam Maragathvallie for their moral support. Not to forget to anyone 
who has involved in this research either directly or indirectly, their encouragement has 
enabled me to complete my final year research report successfully. Thank you so much!  
 
 
 
 
 
TABLE OF CONTENTS 
 
                                                                                                                                 Page 
DECLARATION         ii  
ABSTRACT          iii 
ABSTRAK          v 
ACKNOWLEDGEMENT        vii 
TABLE OF CONTENTS        viii 
LIST OF FIGURES         xi 
LIST OF TABLES         xiii 
LIST OF SYMBOLS AND ABBREVIATIONS     xiv 
CHAPTER I 
INTRODUCTION         1 
CHAPTER II 
LITERATURE REVIEW           4 
2.1 Stem Cells          4 
2.1.1 Properties of Stem Cells      4 
2.1.2 Embryonic Stem Cells       5 
2.1.3 Adult Stem Cells       6 
2.1.4 Adipose Derived Stem Cells      7 
2.1.5 Differentiation         8 
2.2 Bird’s Nest or Edible Bird’s Nest (EBN)               10 
2.2.1 Description                 10 
2.2.2 Traditional Uses of EBN               11 
 
 
2.2.3 Biological Compounds                12 
2.3 Cryopreservation                  14 
2.4 Cryoprotective Agent                 15 
2.5 Research Assays         17 
2.5.1 Morphology of Human Adipose Derived Stem Cells    17 
2.5.2 Induction Medium and Staining      18 
2.5.3 Resazurin Reduction Test      19 
2.5.4 Cell Viability Assays       20 
CHAPTER III 
METHODOLOGY         21 
3.1 Sample Collection        22 
3.2 Isolation          22 
3.3 Trypsinization          23 
3.4 Cryopreservation         23 
3.5 Thawing Cells         24 
3.6 Cell Counting         25 
3.7 Cell Morphology         25 
3.8 Differentiation Assay         25 
3.9 Staining Protocol         27 
3.9.1 Alizarin Red         27 
3.9.2 Oil-Red-O         27 
3.9.3 Alcian Blue Staining       28 
3.10 Resazurin Reduction Test      31 
3.11 Medium Preparation        33 
 
 
3.11.1 Basal Medium        33 
3.11.2 Complete Medium       33 
3.11.3 Phosphate Buffered Saline (PBS) Solution    33 
3.11.4 Osteogenic Induction Medium     34 
3.11.5 Adipogenic Induction Medium     34 
3.11.6 Chondrogenic Induction Medium     35 
CHAPTER IV 
RESULTS          36 
4.1 Cell Viability Test        36 
4.2 Resazurin Test         39 
4.3. Differentiation Ability        44 
4.3.1 Cryoprotectant: 10% DMSO+90% FBS    44 
4.3.2 Cryoprotectant: 5% DMSO+1% EBN+94% FBS   46 
4.3.3 Cryoprotectant: 1% EBN+99% FBS     48 
4.4 Surface Area         50 
CHAPTER V 
DISCUSSIONS         52 
CHAPTER VI 
CONCLUSION         55 
REFERENCES         56 
APPENDIX A         62 
APPENDIX B         63 
APPENDIX C         72 
          
 
 
LIST OF FIGURES 
 
Figure                    Page 
3.1 The overview of the experimental process      21 
3.2 Process of Embedding the Cells into the Paraffin Wax    29 
3.3  Alcian Blue Staining        30 
4.1 Percentage of Cell Viability versus Cryoprotectant     37 
4.2 Standard Curve for 10% DMSO+90% FBS      39 
4.3 Growth Curve for 10% DMSO+90% FBS      39 
4.4 Standard Curve for 5% DMSO+1% EBN+94% FBS    40 
4.5 Growth Curve for 5% DMSO+1% EBN+94% FBS     40 
4.6 Standard Curve for 1% EBN+99% FBS      41 
4.7 Growth Curve for 1% EBN+99% FBS      41 
4.8 Comparison of Cell Number for Two Respective Days    42 
for the Respective Cryoprotectant  
 
4.9 Stem Cells Preserved in 10% DMSO+90% FBS     43 
(Magnification: 4x objective)  
 
4.10 Stem Cells Preserved in 10% DMSO+90% FBS     43 
(Magnification: 10x objective)  
 
4.11 Adipogenic (Magnification: 4x objective)      44 
4.12 Chondrogenic (Magnification: 10x objective)     44 
4.13 Osteogenic (Magnification: 10x objective)      44 
4.14 Stem Cells Preserved in 5% DMSO+1% EBN+94% FBS    45 
(Magnification: 4x objective)  
 
4.15 Stem Cells Preserved in 5% DMSO+1% EBN+94% FBS    45 
(Magnification: 10x objective)  
 
4.16 Adipogenic (Magnification: 4x objective)      46 
 
 
4.17 Chondrogenic (Magnification: 10x objective)     46 
4.18 Osteogenic (Magnification: 10x objective)      46 
4.19 Stem Cells Preserved in 1% EBN+99% FBS     47 
(Magnification: 4x objective)  
 
4.20 Stem Cells Preserved in 1% EBN+99% FBS     47 
(Magnification: 10x objective)  
 
4.21 Adipogenic (Magnification: 4x objective)      48 
4.22 Chondrogenic (Magnification: 10x objective)     48 
4.23 Osteogenic (Magnification: 10x objective)      48 
4.24 Percentage of Surface Area for the Respective     50 
Differentiated Lineages versus Cryoprotectant  
 
4.25 Percentage of Surface Area of Adipogenic      51 
Differentiation versus Cryoprotectant  
 
4.26 Percentage of Surface Area of Chondrogenic    52 
Differentiation versus Cryoprotectant  
 
4.27 Percentage of Surface Area of Osteogenic     53 
Differentiation Lineage versus Cryoprotectant  
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF TABLES 
 
Table           Page 
2.1 Difference between Adult and Embryonic Stem Cells        7 
2.2 Properties of EBN           13 
3.1 Ingredients of Complete Medium               33 
3.2 Ingredients of Osteogenic Induction Medium       34 
3.3 Ingredients of Adipogenic Induction Medium       34 
3.4 Ingredients of Chondrogenic Induction Medium       35 
4.1 Percentage of Cell Viability for Cells        36 
  Preserved in 10% DMSO+90% FBS  
 
4.2 Percentage of Cell Viability for Cells        36 
Preserved in 5% DMSO+1% EBN+94% FBS  
 
4.3 Percentage of Cell Viability for Cells        37 
Preserved in 1% EBN+99% FBS  
 
4.4 Percentage of Resazurin Reduction and        38 
Cell Number for the Respective Cryoprotectant  
 
4.5 Percentage of Surface Area of Cells         49 
Preserved in 10% DMSO+90% FBS  
 
4.6 Percentage of Surface Area of Cells         49 
Preserved in 5% DMSO+1% EBN+94% FBS  
 
4.7 Percentage of Surface Area of Cells         49 
Preserved in 1% EBN+99% FBS  
 
4.8 Percentage of Surface Area of Adipogenesis for the       51 
Respective Cryoprotectant  
 
4.9 Percentage of Surface Area of Chondrogenesis for the      52 
Respective Cryoprotectant  
 
4.10 Percentage of Surface Area of Osteogenesis for the      53 
Respective Cryoprotectant  
 
 
 
LIST OF SYMBOLS AND ABBREVIATIONS 
 
DMSO  Dimethyl sulfoxide 
EBN  Edible bird’s nest 
%  Percentage 
ASC  Adipose derived stem cell 
MSC  Mesenchymal stem cell 
EGF  Epidermal growth factor 
ppm  Parts per million 
mg/kg  Milligram per kilogram 
Con A  Concanavalin A 
PHA  Phytohaemagglutinin 
°C  Degree Celsius 
pH  Power of hydrogen 
FBS  Fetal bovine serum 
°C/minute Degree Celsius per minute 
HES  Hydroxyethyl Starch 
IUPAC International Union of Pure and Applied Chemists 
mV  Millivolts 
TGF-β3 Transforming growth factor beta 3 
NADPH Nicotinamide adenine dinucleotide phosphate 
FADH  Flavin adenine dinucleotide 
FMNH  Flavin mononucleotide  
NADH  Nicotinamide adenine dinucleotide 
 
 
nm  Nanometer  
ATP  Adenosine triphosphate 
PBS   Phosphate Buffered Saline 
rpm  Revolutions per minute 
mL  Millilitre 
Po  Primary culture 
P1  Passage One 
P2  Passage Two 
P3  Passage Three 
Hrs  Hours 
µL  microlitre 
g  Gram 
mg  Milligram 
mm  Millimeter 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER I 
 
INTRODUCTION 
 
Stem cells are cells with the ability of self renewal and contain the ability to produce multi-
lineage differentiation. Currently, to be useful in tissue engineering, stem cells should be 
safe for implantation, possess ability to differentiate into multi-lineages and can be easily 
obtained in large numbers. There are several types of stem cells which are generally useful 
in tissue engineering which are as follows; hematopoietic stem cells, adipose stem cells, 
mesenchymal stem cells and skin stem cells. All these types can easily be accessed and to 
be obtained in large numbers. At the same time, they are safe and do not cause immune-
rejection since the samples are autologous (Pirraco et al., 2011; Vacanti et al., 2014). One 
of the most popular concepts used currently is the regenerative therapy which replaces the 
lost or dysfunctional part in a human body. Using this technique, a lot of focus has been 
given on the cardiovascular diseases (Rosen, Myerburg, Francis, Cole, & Marbán, 2014).  
Adipose tissue which is found throughout the human body and is commonly 
discarded during procedures such as liposuction and cosmetic surgery can be a good source 
of stem cells. Their ability to proliferate at high rate and also to produce multi-lineage 
differentiation has gain interest in both tissue engineering and regenerative medicine to 
treat various diseases and disorders. A lot of these diseases can be treated with stem cells 
which are taken from the patient’s body itself. Since adipose tissue gives rise to 
mesenchymal stem cells, therefore it is possible for autologous transplantation. In order for 
 
 
a patient to benefit from such therapies, the stem cell source should be always made 
available. Therefore, it is important to preserve these cells so that they are always available 
for treatments. Cryopreservation is one of the important methods to preserve cells and 
tissues where it can be used for the recovery of damaged tissues and organs. One of the best 
options for stem cell preservation is the stem cells banks which will maintain cells in a 
viable state for a long period of time. However, donors are suppose to pay for these banks. 
It is also said that a mesenchymal stem cells isolated from an adipose tissue which are 
cryopreserved are equally the same as the freshly isolated mesenchymal stem cells 
(Choudhery, Badowski, Muise, Pierce, & Harris, 2014).  
Cryopreservation of stem cells is mainly to minimize any form of damage to 
biological materials at very low temperatures while freezing and also during storage. This 
issue can be addressed with the addition of a cryoprotective agent. There are two types of 
cryoprotectant used for cell preservation which are as follows; intracellular and 
extracellular cryoprotectant. One of the most commonly used cryoprotectant is the dimethyl 
sulfoxide (DMSO). DMSO is a polar compound which was originally created for the use as 
a solvent. However the use of DMSO may result in the toxicity of cells. The ability of 
DMSO to induce non lamellar structures in phospholipids and to enhance membrane 
permeability may also damage biological membrane at physiological temperature. 
Moreover, DMSO also has the ability to induce cell differentiation indicates that it might 
exert an influence at the genetic regulation level (Yu & Quinn, 1994). There are also some 
natural cryoprotectants which are as follows; sucrose and trehalose which are extracellular 
cryoprotectant. The main usage of these sugars is because the cells do not produce or 
synthesizes these sugars. At the same time, the sugar molecules are too big to enter the cell 
permeable membrane, hence making them an extracellular cryoprotectant. However, 
 
 
research has concluded that extracellular cryoprotectant is not as efficient as the 
intracellular cryoprotectant (Motta, Paraguassú-Braga, Bouzas, & Porto, 2014). 
The bird’s nest or also known as edible bird’s nest (EBN) is a health food with 
many traditional medicinal properties. It is said to maintain the youthful complexion of an 
individual, does speedy recovery from illness, improves appetite, aid in digestion issue and 
also boost the immune system. In the traditional Chinese medicine, it is used for curing 
tuberculosis, dry coughs, suppressing cough and phlegm, improving ulcer, relieving gastric 
troubles and weakness of bronchial ailments (Chan, 2006; Hobbs, 2004; Marcone, 2005). 
The extract of EBN is found to be anti-inflammatory in nature where it has suppressed the 
production of tumor necrosis factor-alpha. Either than that, it is also able to inhibit the 
infections by influenza virus which is facilitated by the N-Acetylneuraminic acid residues 
which are present in the EBN. EBN is made up of 62-63% of protein, 25.62-27.26% of 
carbohydrates, bioactive mucoid and epidermal growth factor which stimulates cell division 
and growth of many epidermal and epithelial tissues (Ma & Liu, 2012; Yang, Cheung, Li, 
& Cheung, 2014). 
Although many research have been carried out using EBN but nothing would 
related to EBN as a cryoprotectant. Therefore, this study was designed to study the ability 
of EBN to act as a cryoprotective agent on human adipose derived stem cells. The 
objectives of this study are as follows: 
1. To evaluate the efficiency of EBN to act as a cryoprotective agent.  
2. To evaluate the differentiation ability to express the following lineages; 
osteogenic, adipogenic and chondrogenic after cryopreservation with the 
respective cryoprotectants (10% DMSO+90% FBS, 5% DMSO+1% 
EBN+94% FBS and 1% EBN+99% FBS). 
 
 
3. To evaluate the proliferative rate of the cryopreserved human adipose 
derived stem cells with the respective cryoprotectants (10% DMSO+90% 
FBS, 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS). 
Problem statement: DMSO is a common cryoprotective agent that is known to cause toxic 
to the cells. Since EBN has exhibited some good properties, therefore, this study is 
designed to evaluate the ability of EBN to either act as a cryoprotectant to substitute DMSO 
or to act as a supplement to DMSO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER II 
 
LITERATURE REVIEW 
 
2.1 Stem Cells 
2.1.1 Properties of Stem Cells 
Stem cells are unspecialized cells that are able to self renew and contain the ability to 
produce multilineage differentiation. Two of their properties are as follows; firstly, stem 
cells contain the ability to divide many times while retaining the undifferentiated state. This 
situation is termed as self-renew. Secondly, under certain or proper conditions these cells 
can be induced to produce specialized cells via differentiation. For example; heart muscle 
cells, blood cells or nerve cells. Some of the sources of stem cells includes; bone marrow, 
embryonic stem cells from inner cell mass, various tissues of the adult body such as fats 
and skin, fertilized and unfertilized eggs, gestational tissues such as umbilical cord, york 
sac and amniotic fluid and embryonic germ cells from developing gonads of the fetus. 
Therefore, stem cells are divided into two main types which are as follows; adult and 
embryonic stem cells. A stem cell can be totipotent cells, pluripotent cells, multipotent 
cells, unipotent cells or differentiated cells depending on the source of cells obtained.  
Traditionally, adult stem cells were thought to give rise to one particular cell type in which 
the tissue resides. For example if a blood forming cell is obtained from bone marrow 
(hematopoietic stem cell), it will generate red blood cells, white blood cells and platelets. 
However further studies suggest that stem cells obtained from tissues may give rise to 
 
 
several different types of cells which are completely different from where they reside which 
is termed as plasticity. For example, hematopoietic stem cell which produces heart muscles 
or blood cells producing neurons. Therefore, extensive studies on using adult stem cells for 
cell based therapies have become very active areas. Stem cells has many benefits, some of 
them are as follows; for gene therapy, to produce tissues and organs which genetically 
matches the patient to replace damaged or diseased parts, to test effects of drugs on a 
specific lineages, for example cardiac muscle cells, helps develop cures for certain diseases 
such as Parkinson, Alzheimer, stroke, arthritis, burns, spinal injury, heart disease, certain 
form of cancer and etc and also can be used to study the development of tissue 
(Chamberlain, Fox, Ashton, & Middleton, 2007; Mani et al., 2008; Stocchero & Stocchero, 
2011). 
2.1.2 Embryonic Stem Cells 
Embryonic stem cells are obtained from embryos that are produced from eggs via in vitro 
fertilization with the permission of the donors and these kinds of stem cells are never 
obtained from a pregnant mother. The embryos that are produced are usually four to five 
days old and are a hollow microscopic ball of cells which is termed as blastocyst. A 
blastocyst contains three structures which are as follows; trophoblast; a layer of cells 
surrounding the blastocyst, blastocoels; the hollow cavity inside the blastocyst and the inner 
cell mass which is made of a group of 30 cells at one end of the blastcoel. Some of the 
advantages of embryonic stem cells are as follows; they are able to proliferate indefinitely, 
both totipotent (ability to produce all types of cells) and pluripotent (ability to produce 
many types of cells) abilities and they are easily grown in culture. However there are some 
disadvantages which are as follows; there is a tendency for these types of cells to be 
malignant or to produce tumors since their gene expression is unstable. Secondly, the moral 
 
 
and human right issues that are involved makes this stem cells least preferred (Biswas & 
Hutchins, 2007; A. Smith, 2001).  
2.1.3 Adult Stem Cells 
Adult stem cells are cells that are undifferentiated found among the differentiated cells in 
an organ or tissue. These cells can self-renew and also has ability to differentiate to produce 
many types of cells of organs and tissues. The main function of an adult stem cell in a 
living organism is to maintain and repair tissues at sites they are found. Some of the sources 
of adult stem cells are bone marrow, skin, fats, blood vessels, liver, gut and etc.  
Some of the advantages of adult stem cells are as follows; does not involve moral issues, 
therefore not controversial, contain pluripotent abilities, ability to differentiate into a 
narrow set of cell types hence it is easier to direct then to a particular lineage, can be 
clinically used for many diseases, tumour formation can be avoided, ability to differentiate 
into different tissue types which is termed as plasticity or transdifferentiation and lastly 
immunorejection avoided by obtaining autologous stem cells; which may protect donor 
from contamination, viral or bacterial infections. However the disadvantages are as follows; 
firstly, the proliferation capacity is limited, short life as compared to embryonic stem cells, 
there is a risk of infection to the recipient if the source is allogenic (cells taken from others), 
risk to the donor during isolation if autologous source is preferred and culturing adult stem 
cells in vitro is difficult and almost impossible for some types of cells as compared to 
embryonic stem cells (Palsson & Bhatia; Young & Black, 2004). Table 2.1 summarizes the 
difference between adult and embryonic stem cells. 
 
 
 
 
 
 
 
 
Table 2.1: Difference between Adult and Embryonic Stem Cells (Palsson & Bhatia) 
Embryonic Stem Cells   Adult Stem Cells 
Pluripotent (ability to produce all types of 
cells). 
Limited capacity to differentiate into 
different types of cells. However, some adult 
stem cells contain plasticity ability. 
Large number of cells can be easily grown 
in culture.  
Culturing adult stem cells in vitro is difficult 
and almost impossible.  
Embryonic stem cells from a donor 
introduced into a patient cause transplant 
rejection. 
Autologous source can be obtained from the 
patient, expended in culture and 
reintroduced into the patient once again. 
This avoids immunorejection. Hence, 
avoiding the immunosuppressive drugs.  
 
2.1.4 Adipose Derived Stem Cells 
Adipose-derived stem cells are important for many therapeutic applications, multipotent 
and are plastic adherent isolated which are obtained through collagenase digestion of 
adipose tissue. Multipotent means ability to produce limited number of cell types. 
Therefore, adipose-derived stem cells can be differentiated into several lineages which are 
as follows; chondrogenic, neurogenic, adipogenic and also osteogenic. Some stromal cells 
exhibit adipose-derived stem cells characteristics and these cells can be isolated from the 
adipose tissue of an adult and grown in vitro and differentiated into adipocytes. Stromal 
cells can be isolated in either large or small amounts from the human adipose tissue. In 
human, the mesenchymal cells will undergo a complex process of transcription and non-
transcription to produce adipocytes which occurs throughout the human life. Adipocyte 
differentiation will result in changes in cell morphology, hormone sensitivity and also gene 
expression (Bunnell, Flaat, Gagliardi, Patel, & Ripoll, 2008).  
There are several terms used to identify an adipose tissue, which are as follows; 
adipose-derived stem cells, adipose-derived adult stem cells, adipose-derived adult stromal 
cells, adipose-derived stromal cells, adipose stromal cells, adipose mesenchymal stem cells, 
lipoblast, pericyte, pre-adipocyte and processed lipoaspirate cells. Since too many terms 
 
 
leads to confusion, therefore the International Fat Applied Technology Society has come up 
with the term adipose-derived stem cells (ASCs) to identify the isolated, multipotent, 
plastic adherent cells. This important as to differentiate it from the plastic adherent adult 
stem cells of bone marrow which is termed as multipotent mesenchymal stromal cells 
(MSCs) (J. M. Gimble, Katz, & Bunnell, 2007). 
2.1.5 Differentiation  
Differentiation is a process of treating the unspecialized stem cells under proper conditions 
to produce specialized cells. Differentiated cells are cells with a specific function; they 
can’t be changed into another cell type or can’t produce stem cells. Since adipose-derived 
stem cells are multipotent, therefore their therapeutic values have created interest for 
regenerative medicine. The differentiation can be initiated with the addition of specific 
induction medium with chemical inducers or cytokines. It is also suggested that 
differentiation is age dependent, where the differentiation capacity is higher in culture for 
younger patients as compared to the older ones.   
Adipogenic differentiation: As the stem cell proliferation takes place, some the cells 
will differentiate into preadipocytes. These preadipocytes will undergo a second 
differentiation where it will begin to be filled with lipid. The lipid accumulation within cell 
vacuoles will result in the droplet appearance. 
Osteogenic differentiation: Osteogenesis can be determined via several methods 
which are as follows; Alizarin Red staining to demonstrate mineralization, measurement of 
calcium and Alkaline Phosphatase (AP) activity and also detection of lineage specific gene 
and protein regulations. During osteogenic differentiation, the stem cell proliferates rapidly 
and will form tightly packed colonies. Sometimes these colonies will result in dense 
nodules which highly elongated spindle shaped cells with large nuclei. 
 
 
Chondrogenic differentiation: Here, differentiation takes places in three steps. 
Proliferation of stem cells will express extracellular matrix called protenin. The protenin 
produced will tell the cells to condense into nodules. Cells in these nodules will become 
chondrocytes which will secrete proteoglycan and collagen which are necessary for the 
formation of cartilage (Bunnell et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2 Bird’s Nest or Edible Bird’s Nest (EBN) 
2.2.1 Description 
The EBN are mainly swiflets, tiny birds about the size of sparrow that feed on insects from 
the following order; Hymenoptera (winged ants, fig wasps and bees), Diptera (flies), 
Coleoptera (small beetles), Homoptera (leafhoppers) and Ephemenoptera (mayflies) (Lim 
et al., 2002). They are found in the following areas; Indian Ocean, Southeast Asia, North 
Australia and also the Pacific. The EBN used for human consumption in the Southeast 
Asian region is mainly from the genus Collocalia and there are 4 main species that are 
consumed which are as follows; Collocalia fuciphaga, Collocalia germanis, Collocalia 
maxima, and Collocalia unicolor (Sankaran, 2001). 
However in Malaysia the main EBN source comes from the swiflet species of 
Aerodromus fuciphagus. These birds construct their nests with their saliva which is 
described as glutinous strands of starch. The saliva comes from a pair of large salivary 
glands under the tongue and is produced after mating and breeding their young ones in the 
nest. The breeding seasons are usually from December to March, April to July and August 
to November (Deraman, 2012). Some of the main areas in Malaysia where EBN is source is 
found are Sitiawan, Teluk Intan, Kota Bharu, Kuala Terengganu, Parit Buntar, Bukit 
Mertajam, Nibong Tebal, Kuantan, Muar, Segamat and many other old townships. EBN 
can be mainly divided into two groups which are house nest and cave nest. In Malaysia, the 
colour of the EBN is used to grade them accordingly. Usually the red coloured EBN which 
is also known as red blood nest is graded as high quality nest; therefore, it is priced 
expensive as compared to others (Norhayati Jr, Azman, & Wan, 2010). 
 
 
 
 
2.2.2 Traditional Uses of EBN 
Some of the main traditional uses of EBN that are associated with enhancing the health are 
as follows; improves the immune system and digestive system which hence improves 
appetite, improves complexion and skin tone and prevents flu, cough, phlegm and asthma. 
Other uses which have been stated are the ability to enhance the renewal of cells and tissues 
and also improving blood circulation and strengthen lungs and kidneys(Lim et al., 2002).  
In the traditional Chinese medicine, the EBN is used for the following; for treating 
consumptive diseases, curing tuberculosis, dry coughs, suppressing cough and phlegm-
dyspnea (difficulty in breathing), alleviating asthma, hemoptysis (coughing blood), 
improving the voice, asthenia, stomach ulcer, relieving gastric troubles, and general 
weakness of bronchial ailments. Either than that, it is also used to nourish the kidneys, 
lungs heart and stomach to aid renal functions, raise libido, strengthen the immune system, 
promote growth, enhance the immune system, improve concentration, increase energy and 
metabolism, and regulate circulation (Chan, 2006; Hobbs, 2004; Kong et al., 1987). 
It is also believed that consuming EBN often can improve physical and mental 
strength and at the same time slows down aging effect hence restoring one’s youthfulness. 
Even though there many health benefits that have been claimed, yet the mechanism of 
action are still unknown and there is no evidence to support the claims (Norhayati Jr et al., 
2010).  
 
 
 
 
 
 
 
2.2.3 Biological Compounds 
The nests that are built by the male swiflets during breeding seasons are entirely from their 
saliva. Some of the birds will include feathers while constructing their nests and this 
amount is always within 10% of the dry weight. The average content of protein that has 
been reported are as follows; (HYDROLYSATES, 2012) at 53.26%, (Marcone, 2005)at 62-
63% and (Kathan & Weeks, 1969) at 32.3%. All 18 types of amino acids that are needed by 
a human body are present in the nest with aspartic acid and serine as the major amino acids 
present. These amino acids are water soluble in nature and aids in skin healing, cell energy 
production, regulates cell function produces antibodies and immunoglobulin which 
enhances immune system . 
The other common group that is found in the nest is carbohydrate in the form of 
glycoprotein. The nest is mainly composed of glycoprotein with the mucin type 
glycoprotein which allows it to serve as lubricant and protective agent. The carbohydrate 
content is found to be at 27.26% (Marcone, 2005). The carbohydrate components are as 
follows; 9% of sialic acid, 7.2% of galactosamine, 5.3% of glucosamine, 16.9% of 
galactose and 0.7% of fucose. However, it is stated that sialic acid is the major substitute of 
carbohydrate in the EBN (Oda, Ohta, Suga, & Aoki, 1998).  
Processed EBN contains a reasonable amount of minerals which are as follows; 
sodium (650 ppm), potassium (110 ppm), calcium (1298 ppm), magnesium (330 ppm), 
phosphorous (40 ppm) and iron (30 ppm). Hence, sodium, potassium, calcium and 
magnesium are said to be the major minerals present in the nest and are mainly important to 
activate enzyme reactions in the body (Marcone, 2005). Table 2.2 explains the properties of 
EBN. 
 
 
 
Table 2.2: Properties of EBN (Chan, 2006; Guo et al., 2006; Ibrahim, Sugimoto, & Aoki, 
2000; Kong et al., 1987; MARNI et al.; Matsukawa et al., 2011; Ng, Chan, & Kong, 1986; 
Yida, Imam, & Ismail, 2014). 
EBN properties Discussion 
Antioxidant activity Some of the amino acids for instance cysteine, 
methionine, histidine, tryptophan and lysine that are 
found in the EBN have been proven for antioxidant 
activity. It is said that the hydroxyl and carboxyl 
groups in the amino acids are responsible for this for 
this activity.  
Epidermal growth factor (EGF)-
like activity and mitogenic 
effects 
The function of EGF is to stimulate the proliferation 
of epidermal and epithelial tissues, in cell culture it 
stimulates thymidine and amino acid incorporation 
into human fibroblasts and also initiates 3T3 fibroblast 
cell division.  
Partially purified swiftlet nest extracts possess the first 
known EGF which induces cell division, tissue 
growth, cellular regeneration and cell-mediated 
immunity.  
It has been demonstrated that the glycoprotein is 
capable of promoting cell growth. The EBN extract 
that contain glycoprotein are responsible for the 
mitogenic response of human peripheral blood 
monocytes to stimulate the Concanavalin A (Con A) 
or Phytohaemagglutinin (PHA). 
Inhibits influenza virus EBN extract has been reported to contain 
haemogglutination which possess an inhibiting action 
against the influenza virus. 
Bacteriostatic and bacteriocidal 
activites 
EBN contains ovortransferrin-like protein which are 
both bacteriostatic and bacteriocidal and is effective in 
fighting against infections. 
Neurological properties One of the functions of sialic acid is for mediating 
gaglioside distribution and structure of the brain. It is 
reported that a good amount of sialic acid contributes 
to neurological and intellectual functions in infants. 
Immunomodulating properties It is said that the glucosamine that is found in the EBN 
contain some immunomodulating effects. 
Improves skin texture Showed that rats’ bone strength and skin thickness 
were increased when administered with 100 mg/kg of 
EBN extract. 
 
 
 
 
 
2.3 Cryopreservation 
Cryopreservation is a method of freezing cells or tissues at low temperatures of -196°C in 
liquid nitrogen where the metabolic activities of the cells are arrested. Generally, water is 
important for living cells to function and therefore we can conclude that freezing of water 
can lead to death of cells. Yet, it is said that freezing can preserve cells for a long period of 
time without disturbing its viability, where it slows or stops certain biochemical reactions 
but accelerates others. The main objective of cryopreservation is to minimize the amount of 
damage to the biological material during freezing at low temperature and storage. The 
cryopreservation can be achieved at -196°C in liquid nitrogen or above -196°C in 
conventional freezer, freeze drying or vitrification. However, it is stated that freezing 
biological material at above -196°C (-130°C to be exact) has lower viability in long terms 
as compared to storage in liquid nitrogen. Therefore, the conventional freezer is only used 
for microbial suspension and for mammalian tissue culture with large number of cells. 
During freezing, the cells are exposed continuously to hypertonic solution, therefore it is 
necessary to remove a certain amount of water from the cells osmotically to avoid 
intracellular freezing. At a slow cooling rate, there is equilibrium between the cells and it’s 
external environment. However, the external environment freezes before the internal 
medium due to the protective cell membrane layer. This will make the external 
environment more hypertonic and thus there forcing the water to flow out from the cells. 
Removal of too much of water from the cells may result in the increase of solutes within 
the cells; hence the environment is not in equilibrium. At a higher cooling rate there is less 
time for the water to flow out of cells resulting in the formation of intracellular ice and 
hence causing the cells to be lethal. Therefore, an optimum cooling rate is needed to be 
achieved between these two situations. A summary; at slow rate of cooling, cells will die 
 
 
due to exposure to hypertonic condition for a long period of time whereas, for high rate of 
cooling, the cells die due to the formation of intercellular ice. Other challenges that maybe 
encountered by the cells are as follows; increase in ionic concentration, extreme viscous of 
solution, pH changes, cells becomes closed packed, dehydration and also precipitation of 
salts (Anchordoguy, Cecchini, Crowe, & Crowe, 1991; Ozkavukcu & Erdemli, 2002). 
2.4 Cryoprotective Agent 
The main goal of cryopreservation is to replace some of the water content within the cell 
with other components that will not result in large ice crystals. Some of the examples of 
these components are DMSO and glycerol. They are generally non-toxic, contains low 
molecular weight and also able to permeate cells. Usually cells that are to be freezed in 
liquid nitrogen are suspended in this component which is mixed with a medium and serum. 
As the medium begins to freeze, the salt concentration in the external environment becomes 
greater as compared to the inner of the cells hence forcing water out of the cells and to be 
replaced by this cryoprotectant. Thus, reducing cellular damage during freezing process. 
Some of other functions of a cryoprotectant are as follows; protects cells by reducing cell 
shrinkage, reduces the fraction of solution that is to be frozen and minimizes the formation 
of intracellular ice. A cryopreservation medium will contain the following; cryoprotectant, 
base medium and protein source. The cryoprotectant is used to protect cells from 
mechanical and physical stress and also reducing cellular damage by reducing the 
formation of ice crystals. As for the protein source, the most common one used is the fetal 
bovine serum (FBS) which serves to protect the cells from any freeze-thawing process 
stress. Cells are usually frozen slowly at 1°C/minute (Ozkavukcu & Erdemli, 2002). 
Generally, DMSO will permeate into the cell membrane and reduces the amount of 
ice crystal formed both internally and externally. However, osmosis and dehydration will 
 
 
still occur but at a very much lower temperature, hence allowing for the absence of 
formation of intracellular ice crystals. Another less commonly used cryoprotectant which is 
a high molecular weight polymer which does not permeate the cell membrane yet 
contributes to the same effect is the Hydroxyethyl Starch (HES). HES is preferable used 
with DMSO. Cryoprotectant such as glycerol is able to form hydrogen bonds with the head 
of the lipid which are present in the membrane, hence stabilizing the lipid membrane which 
is important for extreme dehydration situation (Arakawa, Carpenter, Kita, & Crowe, 1990). 
The amount of cell shrinking and also re-swelling depends on cryoprotectant concentration 
as well as the permeability of the cell membrane to both water and cryoprotectant used. As 
the cells are thawed, a reverse process will take place; the cells will first swell and then 
shrink. If the cell expands too much than it may lead to cell damage and hence it can be 
prevented by stepwise removal of the cryoprotectant (Gilmore, Liu, Woods, Peter, & 
Critser, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5 Research Assays 
2.5.1 Morphology of Human Adipose Derived Stem Cells  
After 24 hours of cell isolation, the ASCs would adhered to the respective culture flask, 
where as the non adherent cells for example; red blood cells would be floating in the 
culture. MSCs are plastic-adherent and posses a spindle shaped cells, which develops into 
visible colonies after approximately three days. After the second passage, human adipose 
derived stem cells will apprear more uniform with fibroblast-like shape which is similar to 
a bone marrow stromal cell. 
Adipogenic differentiation: According to (Zhu et al., 2008), no lipid droplets would 
be observed in an undeffientiated ASCs, where as ASCs differentiated into adipocytes via 
mutiple passage showed intracellular lipid filled droplets in almost 80-90% of the cells in 
adipogenic media. The cells contain lipid vesicles with the majority of intracellular space 
occupied by droplets and lipid vesicles which gives an expanded morphology. However, at 
higher passage number, the differentiation potential decreased with only 40-55% ASCs 
differentiated into adipocytes (Csaki, Matis, Mobasheri, Ye, & Shakibaei, 2007).  
Osteogenic differentiation: The culture that was incubated for about 3 weeks, 
showed multiple layers of cells which could also give rise to dense nodules from which 
radiated highly elongated spindle-shaped cells with large nuclei. The ASCs that undergo 
osteogenic differentiation is about 90% at passage 4 where the mineralization nodules were 
visible to the naked eye. As the passage number increases, the differentiation capacity 
decreases. 
Chondrogenic differentiation: ASCs cultured (micromass pellet culture or high 
density culture) in chondrogenic induction medium contains a round, nodule like 
morphology (Csaki et al., 2007). 
 
 
2.5.2 Induction Medium and Staining  
Adipogenesis: Isobutyl-methylxanthine, insulin and dexamethasone are added to the 
adipogenic induction medium. Insulin promotes the differentiation of human adipose-
derived stem cells into adipocytes. It is also proven that glucocorticoids in the presence of 
insulin are able to promote differentiation of MSCs towards adipogenic lineage. Oil red O 
staining can be done to show the presence of intracellular lipid vacuoles (Rampersad, 
2012). 
Osteogenesis: Ascorbic acid, β-glycerophosphate, and dexamethasone are added to 
the osteogenic induction medium. Dexamethasone is needed for osteogenesis of stem cells 
as well as for the formation of bone nodule. Ascorbic acid on the other hand functions as a 
cofactor in hydroxylation of proline and lysine residues in collagen and also increases the 
synthesis of non-collagenous bone matrix proteins. β-glycerophosphate is important for the 
calcification of the extracellular matrix. Alizarin red staining can be done to show the 
presence of a calcified extracellular matrix (Rampersad, 2012). 
Chondrogenesis: Dexamethasone and TGF-β3 are added to the chondrogenic 
induction medium promotes chondrogenesis. Glucocorticoids promote chondrogenic 
differentiation by enhancing the expression of the cartilage extracellular matrix gene 
(Derfoul, Perkins, Hall, & Tuan, 2006). Alcian blue staining can be done to show the 
presence of proteoglycans (Guzzo, Scanlon, Sanjay, Xu, & Drissi, 2014).The average 
percentage of mineralization or lipid vacuoles or proteoglycans area against the surface area 
can be determined via images taken after their respective staining. 
 
 
 
 
 
2.5.3 Resazurin Reduction Test 
Alamar blue is used to monitor the reducing environment of a living cell. The active 
ingredient, resazurin is water soluble, non-toxic, stable in medium and possesses cell 
membrane permeability. Resazurin (IUPAC name: 7-hydroxy-10-oxidophenoxazin-10-ium-
3-one) is also known as diazo-resorcinol, azoresorcin, resazoin and resazurine. This test 
was first used to assess bacterial and yeast contamination in milk in the year 1929. 
Resazurin; a highly dichromatic solution is a blue non-fluorescent dye that will be reduced 
into resorufin, which is highly fluorescent and pink in color. The function of the dye is to 
act as an intermediate to accept electron in the electron transport chain without interfering 
the normal transfer of electrons. The oxidation-reduction potential of Alamar blue is +380 
mV at pH 7.0, 25 °C. Alamar blue can be reduced by the following; NADPH, FADH, 
FMNH2, NADH and cytochromes. Once the indicator dye accepts the electrons, the non-
fluorescent blue color is reduced to pink color. Other enzymes such as diaphorases, 
NAD(P)H:quinone oxidoreductase, dihydrolipoamine dehydrogenase, flavin reductase 
within the cytoplasm and the mitochondria reductases may also reduce the Alamar blue. 
Therefore, the Alamar blue reduction is not solely dependent on the electron transport 
where as it can be also the cellular metabolism. The oxidation-reduction state allows the 
measurement to be either quantitative; colorimetric and fluorometric readings or 
qualitative; changes in color indicating the presence and absence of viable cells. 
Spectrophotometric absorbance will be taken at two wavelengths which are as follows; 570 
and 600 nm or 540 and 630 nm. Absorbance values will differ according to the microtiter 
plate. The fluorescence signals are measured at an excitation wavelength of 530–560 nm 
and an emission wavelength of 590 nm (Rampersad, 2012). 
 
 
 
2.5.4 Cell Viability Assays 
Cell viability assays are commonly used for drug screening. There are various cell 
functions to determine this which are as follows; ATP and coenzyme production, 
nucleotide uptake an enzyme activity, cell adherence and cell membrane permeability. 
Generally, viability assays measures the percentage of viable cells in a suspension which 
can be done via dye exclusion stain. Here, cells with intact membrane will exclude the dye 
while the cells without an intact membrane with uptake the dye. Examples of dye exclusion 
stain are as follows; Trypan Blue, erythrosine and naphthalene black. Trypan blue is 
commonly used for measure viability by staining the dead cells (Freshney). It is a rapid, 
simple and inexpensive method to assess cell viability (Longo-Sorbello, Say, m, Banerjee, 
& Bertino, 2006). In this method, the viability of the cells is determined by counting the 
unstained cells with the aid of a microscope (Freshney). According to (Longo-Sorbello et 
al., 2006) the dye exclusion test is the ability of the viable cells to be impermeable to the 
following dyes; Trypan Blue, erythrosine, naphthalene black and other dyes. When the 
security membrane is compromised, there is an uptake of dye by the non viable cells which 
will appear as dark blue color where as the viable cells which was not stained will appear as 
clear with refractile ring around them. One of the down points of trypan blue staining is 
that, the dye can’t be used to differentiate between healthy cells and the viable cells that are 
losing their cell functions. 
 
 
 
 
 
 
 
 
 
CHAPTER III 
 
METHODOLOGY 
 
Figure 3.1 shows the overview of the experimental process. Subcutaneous adipose tissue 
that was collected was isolated within 24 hours and was cultured up to second passage. 
Then, the cells were subjected to cryopreservation for a month in liquid nitrogen. After a 
month, the cells were thawed and were grown to sufficient amount to carry out the 
following research assays: cell viability test, resazurin test, morphology observation and 
differentiation assay. The cells were differentiated into the following lineages: adipogenic, 
chondrogenic and osteogenic and the respective stains were carried out. 
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Figure 3.1: The overview of the experimental process 
 
 
 
 
 
 
 
 
 
 
3.1 Sample Collection 
The subcutaneous adipose tissue was collected from the C-section patients from Dewan 
Bedah, Pusat Perubatan Universiti Malaya. The collected sample was placed in a container 
containing saline solution. Prior to collection, the patient’s were presented with a consent 
form. This is mainly to protect the human rights. After collection, the sample was brought 
back to the laboratory for isolation. The container containing the sample was wrapped with 
tissue to prevent any form of exposure to the sun.  
3.2 Isolation 
Under the laminar air flow, the subcutaneous adipose tissue that was collected was removed 
from the container and was placed on a sterile petri dish and was washed twice with 
Phosphate Buffered Solution (PBS). Than, with the aid of a sterile tweezer and scissor, the 
blood vessels were removed and the remaining tissue was finely chopped. The resulting 
tissue was place into a sterile Falcon tube and 6 mL of Collagenase Type I was added to it. 
Than, the tube was placed into the shaking incubator for 10 minutes, 37°C and 250 rpm and 
was later centrifuged at 10 minutes and 1500 rpm. After centrifuging, the supernatent was 
removed with the aid of a pastuer pipette and the remaining solution was washed with PBS. 
10 mL of PBS was added and was vortexed and was centrifuged for 10 minutes and 1500 
rpm This step is to remove all the oily substances. Than, the supernatent was removed with 
the aid of a pastuer pipette. 2 mL of complete medium was added to the pellet that 
remained in the tube and was dispersed with the aid of a pipette. The medium containing 
the dispersed pellet was divided into two T 25 Flasks. Finally, 5 mL of complete medium 
was added to both the flasks (Po) and was incubated at normoxia condition; 21% O2, 5% 
CO2 for 24 hours before viewing under the microscope (Zuk et al., 2002).  
 
 
 
3.3 Trypsinization 
After 24 hours, the cells were viewed under the microscope and the culture medium was 
replaced to remove the non-adherent cells. The culture medium was renewed every 2 to 3 
days. The human adipose derived stem cells primary culture (Po) was grown to 90% 
confluence. Once it has reached 90% confluence, the cells were detached from the culture 
flasks with trypsin-EDTA (Gibco). The cell culture was grown up to passage 3 (P3) which 
was used for further experiment. Once the cell culture has reached confluence, the cell 
culture was trypsinised. The cells were washed with 5 mL PBS. Then, 4 mL of trypsin was 
added to the culture and was incubated for 5 minutes. After 5 minutes, the cells were 
viewed under the microscope to ensure the cells were detached from the flask. Once the 
cells were detached, 5 mL of complete medium was added to the flask to deactivate the 
function of trypsin. All the solution was then transferred into a Falcon tube and was 
centrifuged for 10 minutes, 1500 rpm. The supernatant was then removed with the aid of a 
Pasteur pipette leaving behind the pellet. 4 mL of complete medium was added to the pellet 
and was suspended with the aid of the pipette and was divided into four T 25 Flasks. 
Finally, complete medium was added to all the flasks and was incubated at normoxia 
condition for 24 hours before viewing under the microscope. This process was repeated 
until it reaches P3 (Zhu et al., 2008). 
3.4 Cryopreservation 
In this research, cells were preserved in the respective cryoprotectant which are as follows; 
10% DMSO+90% FBS (Serves as Control), 5% DMSO+1% EBN+94% FBS and 1% 
EBN+99% FBS. 
For all the three groups above, the cells were grown up to P2 and once it reaches 
confluence, the cells were cryropreserved. Once the cell culture has reached confluence, the 
 
 
cell culture was trypsinised. The cells were washed with 5 mL PBS. Then, 4 mL of trypsin 
was added to the culture and was incubated for 5 minutes. After 5 minutes, the cells were 
viewed under the microscope to ensure the cells were detached from the flask. Once the 
cells were detached, 5 mL of complete medium was added to the flask to deactivate the 
function of trypsin. All the solution was then transferred into a Falcon tube and was 
centrifuged for 10 minutes, 1500 rpm. The supernatant was then removed with the aid of a 
Pasteur pipette leaving behind the pellet.  1 mL of the respective cryoprotectant was added 
to the pellet and was suspended with the aid of a pipette and was transferred into a cryovial. 
The cryovials were placed into Mr. Frosty Freezing Container. The system is designed to 
achieve a rate of cooling very close to -1°C/minute, the optimal rate for cell preservation. 
The container was placed in -80°C overnight. This step is important because the cells must 
be frozen slowly which done by the Mr. Frosty Freezing Container. Then, the vials were 
transferred into the liquid nitrogen tank the following day. The cells were cryopreserved for 
a month (Liu et al., 2008). 
3.5 Thawing Cells 
After one month, the cells that were cryopreserved were thawed. The vials were placed in 
the water bath at 37°C. Once it has been thawed, under the laminar air flow, 10 mL of 
complete medium was added to the cells and was centrifuged at 2000 rpm for 10 minutes. 
Then, the supernatant was removed with the aid of a pastuer pipette leaving the pellet 
behind where 3 mL of complete medium was added to it. The resulting solution were 
suspended. Separately, 90 µL was taken out with aid of a pipette and were transferred into 
the centrifuge tube for cell counting. The remaining solution was transferred into a T 25 
flask and appropriate amount of complete medium was added to it (Koch, Heerkens, 
Thomsen, & Betts, 2007).  
 
 
3.6 Cell Counting 
10 µL of trypan blue was added to 90 µL of the solution containing cells which was taken 
out earlier and was suspended with the aid of a pipette. 20 µL of the resulting solution was 
taken and was placed onto hemocytometer. Cell counting was done under the microscope 
(4x objective). The non-viable cells was stained blue, viable cells remained opaque. Cell 
counting was done in triplicates to obtain average (Louis & Siegel, 2011).  Equation I 
below shows the formula to calculate the percentage of cell viability. 
Equation I 
Percentage of Cell Viability =  Total number viable cells  X  100% 
                                                   Total number of cells 
 
3.7 Cell Morphology 
The cell morphology was determined by observing the morphological characteristics of the 
MSCs. The cell culture flasks were examined at all medium re-feeding intervals at two to 
three days to detect abnormalities in cell morphology. All MSCs should possess fibroblast-
like morphology and at the same time must be plastic-adherent. Once the cells have reached 
confluence at passage 3, the cell culture was viewed at 4x and 10x objectives under the 
microscope and images were taken (J. Gimble & Guilak, 2003; Zhu et al., 2008). 
 
 
 
 
 
 
 
 
 
3.8 Differentiation Assay  
Once the cells have reached confluence at P3, the ASCs were seeded into 6 well plates and 
were expended to 90% confluence. Osteogenic differentiation was carried out for 21 days. 
ASCs were maintained at normoxia condition and the culture medium (osteogenic 
induction medium) will be replaced every 2 days. After 21 days, the cells were stained with 
Alizarin Red solution to determine the calcium deposits (Zhu et al., 2008). 
At the confluence of P3, ASCs were seeded into 6 well plates and were expended to 
70% confluence. Adipogenic differentiation was carried out for 21 days. ASCs were 
cultured in adipogenic induction medium and were maintained at normoxia condition. After 
2 days, adipogenic induction medium was removed and was replaced with complete 
medium for the next 2 days. Cyclic treatment was continued for 21 days. After 21 days, the 
cells were stained with Oil-red-O Solution. Lipid droplet formation was detected using this 
stain to assess MSCs differentiation towards adipocytic phenotype (Zhu et al., 2008). 
As for chondrogenic differentiation, at P3, cells were seeded into the T 75 flask and 
were expended to 90% confluence. Once it has reached confluence, the cells were detached 
and were placed into the 50 mL Falcon tube and were centrifuged for 10 minutes, 2500 
rpm. The pellet formed was cultured in the chondrogenic induction medium and was 
maintained at normoxia condition. The culture medium was replaced every 2 days for 21 
days. After 21 days, the pellet was fixed, dehydrated, cleared and infiltrated and embedded 
in paraffin wax. The specimen was sectioned and fished on slides. Then, Alcian Blue 
staining was carried out and the resulting slide was viewed under the microscope (Sudo et 
al., 2007; Zhu et al., 2008).  All the three lineages were stained and were viewed under the 
microscope at appropriate objective. Multiple images were taken which were used for 
surface area determination. 
 
 
3.9 Staining Protocol 
3.9.1 Alizarin Red  
To prepare the Alizarin Red solution, 2g of Alizarin Red powder was mixed with 100 mL 
of deionized water in a beaker with the aid of a stirrer. Under the laminar air flow, the 
solution was filtered through a 0.25 mm syringe filter (De Bari, Dell'Accio, Tylzanowski, 
& Luyten, 2001).  
Staining Procedure 
Under the laminar air flow, the osteogenic induction medium was removed from the 6 well 
plates and the cells were fixed with 2 mL of 10% Formalin and were incubated at 4°C for 
10 minutes. After 10 minutes, formalin was removed and was washed with deionized water. 
Then, the water was removed from each well and 2 mL of deionized water was added to 
each and was left for incubation between two to five minutes at room temperature. After the 
incubation period, the deionized water was removed and 2.5 mL of Alizarin Red solution 
(pH 4.1-4.3) was added to each well and was incubated at room temperature for 10 minutes. 
The stained cells were then extensively washed with PBS to remove excess stain and any 
nonspecific precipitation. Then, the plates were viewed under the microscope (10x 
objectives). The calcium deposition on the differentiated cells was represented by the 
positive red staining (De Bari et al., 2001; Ovchinnikov, 2009). 
3.9.2 Oil-Red-O  
Under the laminar air flow, a fresh 60% Oil-red-O working solution was prepared from a 
stock solution (300 mg Oil-red-O powder in 100 mL isopropanol), was left for 10 minutes 
and was filtered through a 0.25 mm syringe filter (De Bari et al., 2001). 
 
 
 
 
Staining Procedure 
Under the laminar air flow, the medium was removed from the 6 well plates and the cells 
were fixed with 2 mL of 10% Formalin and were incubated at 4°C for 10 minutes. After 10 
minutes, formalin was removed and was washed with deionized water. Then, 60% 
isopropanol working solution was prepared. The water was removed from each well and 1 
mL of 60% isopropanol was added to each and was left for incubation between two to five 
minutes at room temperature. After the incubation period, the , 60% isopropanol was 
removed and 2.5 mL of Oil-Red-O working solution was added to each well and was 
incubated at room temperature for 10 minutes. The stained cells were then washed with 
PBS to remove the residual Oil-Red-O. However, the stained cells were not washed 
extensively to maintain the hydration for clear viewing. Then, the plates were viewed under 
the microscope (4x objective). The lipid formation that was detected using this stain 
represented the differentiation of MSCs towards adipocytic phenotype (De Bari et al., 
2001). 
3.9.3 Alcian Blue Staining 
After 21 days, the medium was removed and the micromass culture pellet was washed with 
PBS. For histological analysis, the pellet was first fixed in 10% Formalin for 24 hours. 
Then, the pellet was dehydrated in a graded ethanol series, cleared with xylene, infiltrated 
with paraffin wax and was embedded in paraffin wax. Next, the specimens were cut into 5 
mm thick sections with the aid of a microtome and the paraffin sections were fished onto 
slides which were dried on a hot plate at 37°C (De Bari et al., 2001). Figure 3.2 shows the 
overview process of embedding the cells into the paraffin wax. 
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Figure 3.2: Process of Embedding the Cells into the Paraffin Wax 
 
The slides with the paraffin sections were deparaffinised in xylene, rehydrated through a 
serious of ethanol, rinsed in distilled water and was stained with Alcian Blue to assess the 
proteoglycan content. Then, the stained tissue sections were mounted with DPX mounting 
and were visualized under the light microscope (10x objective). The differentiated cells 
were stained in light blue color (De Bari et al., 2001). Figure 3.3 shows the steps involved 
in the Alcian Blue staining. 
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Figure 3.3: Alcian Blue Staining 
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3.10 Resazurin Reduction Test 
As for resazurin test, the cells were seeded into the 24 well plate based on Equation I and II 
below. 
Equation I 
Cells per mL = the average count per square x the dilution factor x 104 (count 10 squares) 
Equation II 
Cells per µL =  40 000            x the dilution factor x 100 
                       Cells per mL 
 
After seeding, the plate was incubated for 24 hours under normoxia condition. The 
resazurin reduction test was carried out on day 1, day 3, day 7, day 10 and day 14. Under 
the laminar air flow, after 24 hours of seeding, the medium was removed and was washed 
with PBS. Then, in the dark, 1000 µL (1 mL) of resazurin blue dye was added to the wells 
containing cells and two empty wells which serve as control. Once the dye has been added, 
the plate was wrapped with aluminium foil and was incubated for three hours under 
normoxia condition. After 3 hours, the plate was placed onto the shaking incubator for 10 
minutes, 30 rpm. Next, under the laminar air flow, in the dark, 100 µL was taken from each 
well and were transferred into the 96 well plate. Triplicates from each well were done. The 
96 well plate was wrapped with aluminium foil and was subjected to the microplate reader. 
The data obtained from the microplate reader will show the proliferation rate of the samples 
(O'Brien, Wilson, Orton, & Pognan, 2000). Using the data obtained, the following results 
were calculated using Equation III and IV below to plot both the standard and growth 
curve. 
 
 
 
 
 
 
Equation III 
 
Percentage of Resazurin Reduction = (εOX) λ2Aλ1 - (εOX) λ1Aλ2        X 100 
                                                                 (εRED) λ1A’λ2 - (εRED) λ2A’λ1    
 
λ1 = 570 
λ2 = 600  
(εOX)λ2 = 117,216  
(εOX)λ1 = 80,586 
(εRED)λ1 = 155,677  
(εRED)λ2 = 14,652 
Aλ1 = Observed absorbance reading for test well  
Aλ2 = Observed absorbance reading for test well  
A’λ2 = Observed absorbance reading for negative control well  
A’λ1 = Observed absorbance reading for negative control well 
 
Equation IV 
y = 0.0004x 
y = Percentage of Resazurin Reduction 
x = Number of cells 
 
 
 
 
 
 
 
 
3.11 Medium Preparation 
3.11.1 Basal Medium 
Basal medium is a cell culture medium which  is a complex mixture of salts, carbohydrates, 
vitamins, amino acids, metabolic precursors and trace elements. One packet of F12: 
DMEM powder (Commercial) and 1.2g of sodium bicarbonate was added to 1000 mL of 
distilled water in a beaker and were mixed with the aid of a stirrer. Then, the pH was 
adjusted to 7.2 with the aid of a pH meter. Under the laminar air flow, the medium was 
filtered with the aid of a vacuum pump (A. G. Smith, 1991). 
3.11.2 Complete Medium 
To enhance cell growth, growth factors, hormones and other proteins are added to the basal 
medium. Often this is accomplished by supplementing the basal medium with serum. The 
resulting medium is referred to as complete medium. Under the laminar air flow the 
ingredients in Table 3.1 were mixed together and were filtered. 
Table 3.1: Ingredients of Complete Medium (A. G. Smith, 1991) 
Ingredients Volume (mL) 
Basal medium (F12: DMEM) 435 
10% FBS 50 
1% antibiotic-antimycotic solution 5 
1% glutamate 5 
1% ascorbic Acid 5 
Total 500 
 
3.11.3 Phosphate Buffered Saline (PBS) Solution 
PBS is buffer solution commonly used in biological research mainly to wash tissues and 
cells. It is a water-based salt solution containing sodium phosphate, sodium chloride and in 
some formulations, potassium chloride and potassium phosphate. Five PBS tablets were 
added to 1000 mL of distilled water in a beaker and were mixed with the aid of a stirrer. 
 
 
Then, the pH was adjusted to 7.2 with the aid of a pH meter. The PBS solution was 
autoclaved (A. G. Smith, 1991). 
3.11.4 Osteogenic Induction Medium 
Induction medium is a medium that facilitate the differentiation of cells into the specific 
lineage. Under the laminar air flow, in the dark, the ingredients in Table 3.2 were mixed 
together and were filtered. 
Table 3.2: Ingredients of Osteogenic Induction Medium (Peister et al., 2004) 
Ingredients Volume 
Complete medium 98 mL 
β-glycerophosphate 1.2 mL 
Ascorbate-2-Phosphate 1 mL 
Dexamethasone 100 µL 
 
3.11.5 Adipogenic Induction Medium 
Under the laminar air flow, in the dark, the ingredients in Table 3.3 were mixed together 
and were filtered. 
Table 3.3: Ingredients of Adipogenic Induction Medium (Peister et al., 2004) 
Ingredients Volume 
Complete medium 97 mL 
Indomethacin 1 mL 
Insulin Transferrin Selenium (ITS) 588 µL 
3-Isobutyl-1-methylxanthine (IBMX) 2.2 mL 
Dexamethasone 1 mL 
 
 
 
 
 
 
 
 
 
3.11.6 Chondrogenic Induction Medium 
Under the laminar air flow, in the dark, the ingredients in Table 3.4 were mixed together 
and were filtered. 
Table 3.4: Ingredients of Chondrogenic Induction Medium (Peister et al., 2004) 
Ingredients Volume 
Complete medium  97.5 mL 
Insulin Transferrin Selenium (ITS) 1 mL 
Insulin Growth Factor-1 (IGF-1) 50 µL 
Ascorbate-2-Phosphate 1.2 mL 
Dexamethasone 100 µL 
L-proline 100 µL 
Transforming growth factor beta 3 (TGF-β3) 10 µL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER IV 
 
RESULTS 
 
4.1 Cell Viability Test 
The cell viability was carried out after thawing the cells and growing it to a confluence of 
90% in a T25 flask. Table 4.1, 4.2 and 4.3 shows the percentage of cell viability for cells 
preserved in the 10% DMSO+90% FBS, 5% DMSO+1% EBN+94% FBS and 1% 
EBN+99% FBS respectively. The bar graph depicted in Figure 4.1 shows the comparison 
for the percentage of cell viability (using the mean value) for cells preserved in 10% 
DMSO+90% FBS, 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS. 
 
Table 4.1: Percentage of Cell Viability for Cells Preserved in 10% DMSO+90% FBS 
10% DMSO+90% FBS 
Non-viable cells Total cells Viable cells Viability (%) 
4 135 131 97.04 
14 112 98 87.50 
15 120 105 87.50 
17 131 114 87.02 
4 115 111 96.50 
9 119 110 92.44 
Mean 91.33 
Standard Deviation 4.66 
Standard Error 1.90 
 
 
 
 
 
Table 4.2: Percentage of Cell Viability for Cells Preserved in 5% DMSO+1% EBN+94% 
FBS 
5% DMSO+1% EBN+94% FBS 
Non-viable cells Total cells Viable cells Viability (%) 
29 136 107 78.68 
19 145 126 86.90 
15 107 92 85.98 
21 110 89 80.91 
21 85 64 75.29 
24 105 81 77.14 
Mean 80.82 
Standard Deviation 4.74 
Standard Error 1.93 
 
 
Table 4.3: Percentage of Cell Viability for Cells Preserved in 1% EBN+99% FBS 
1% EBN+99% FBS 
Non-viable cells Total cells Viable cells Viability (%) 
35 72 37 51.39 
46 84 38 45.24 
16 81 65 80.25 
27 75 48 64.00 
25 62 37 59.68 
27 73 46 63.01 
Mean 60.59 
Standard Deviation 12.04 
Standard Error 4.92 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Percentage of Cell Viability versus Cryoprotectant 
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There is a significant difference (P<0.05) between all the 
three groups of the cryoprotectant. 
 
 
4.2 Resazurin Test 
Table 4.4 below shows the percentage of resazurin reduction and the respective number of 
cells for the cells preserved in 10% DMSO+90% FBS, 5% DMSO+1% EBN+94% FBS 
and 1% EBN+99% FBS. The number of cells was calculated based on the percentage of 
resazurin reduction for day 1, 3, 7, 10 and 14. Figure 4.2, 4.4 and 4.6 shows the standard 
curve (percentage of resazurin reduction versus the respective days) for 10% DMSO+90% 
FBS, 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS respectively. Whereas, 
Figure 4.3, 4.5 and 4.7 shows the growth curve (cell number versus the respective days) for 
10% DMSO+90% FBS, 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS 
respectively. 
Table 4.4: Percentage of Resazurin Reduction and Cell Number for the Respective 
Cryoprotectant  
 
 
 
 
 
 
 
 
 
 
 
 
 
Day 
10% DMSO+90% FBS 
5% DMSO+1% EBN+94% 
FBS 1% EBN+99% FBS 
Percentage of 
resazurin 
reduction (%) 
Number 
of cells 
Percentage of 
resazurin 
reduction (%) 
Number 
of cells 
Percentage of 
resazurin 
reduction (%) 
Number 
of cells 
1 19.59 48975 14.32 35800 14.72 36800 
3 25.20 63000 15.98 39950 16.35 40875 
7 26.02 65050 28.30 70750 16.74 41850 
10 28.41 71025 31.47 78675 23.48 58700 
14 40.72 101800 45.12 112800 12.01 30025 
 
 
 
 
 
Figure 4.2: Standard Curve for 10% DMSO+90% FBS 
 
 
 
Figure 4.3: Growth Curve for 10% DMSO+90% FBS 
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Figure 4.4: Standard Curve for 5% DMSO+1% EBN+94% FBS 
 
 
 
Figure 4.5: Growth Curve for 5% DMSO+1% EBN+94% FBS 
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Figure 4.6: Standard Curve for 1% EBN+99% FBS 
 
 
 
Figure 4.7: Growth Curve for 1% EBN+99% FBS 
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Figure 4.5 below shows the comparison the comparison for number of cells for day 3, 10 
and 14 for cells preserved in the 10% DMSO+90% FBS, 5% DMSO+1% EBN+94% FBS 
and 1% EBN+99% FBS respectively. The standard error of mean is presented above each 
bar. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Comparison of Cell Number for Two Respective Days for the Respective 
Cryoprotectant 
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Day 3: There is a significant difference (P<0.05) which is indicated by * * 
between the groups of the cryoprotectant. 
Day 10:  There is no significant difference (P>0.05) between all the three 
groups of the cryoprotectant. 
Day 14:  There is a significant difference (P<0.05) between all the three 
groups of the cryoprotectant. 
 
 
 
 
4.3. Differentiation Ability 
4.3.1 Cryoprotectant: 10% DMSO+90% FBS 
Figure 4.9 and 4.10 shows the morphology for cells preserved in 10% DMSO+90% FBS at 
a magnification of 4x and 10x objective, before staining.   
I. Before Staining 
          
Figure 4.9: Stem Cells Preserved in 10% DMSO+90% FBS (Magnification: 4x objective) 
 
Figure 4.10: Stem Cells Preserved in 10% DMSO+90% FBS (Magnification: 10x 
objective) 
  
 
 
 
 
 
 
 
Figure 4.11, 4.12 and 4.13 shows cells stained with the respective stains for the 
differentiation assay for cells preserved in 10% DMSO+90% FBS. Adipogenic 
differentiation was stained with Oil Red-O stain, whereas chondrogenic and Osteogenic 
were stained with Alcian blue and Alizarin red respectively. 
II. After Staining 
 
Figure 4.11: Adipogenic (Magnification: 4x objective) 
 
Figure 4.12: Chondrogenic (Magnification: 10x objective) 
 
Figure 4.13: Osteogenic (Magnification: 10x objective) 
 
 
 
4.3.2 Cryoprotectant: 5% DMSO+1% EBN+94% FBS 
Figure 4.14 and 4.15 shows the morphology for cells preserved in 5% DMSO+1% 
EBN+94% FBS at a magnification of 4x and 10x objective, before staining.   
I. Before Staining 
 
Figure 4.14: Stem Cells Preserved in 5% DMSO+1% EBN+94% FBS (Magnification: 4x 
objective) 
 
Figure 4.15: Stem Cells Preserved in 5% DMSO+1% EBN+94% FBS (Magnification: 10x 
objective) 
 
 
 
 
 
 
 
 
Figure 4.16, 4.17 and 4.18 shows cells stained with the respective stains for the 
differentiation assay for cells preserved in 5% DMSO+1% EBN+94% FBS. 
II. After Staining 
 
Figure 4.16: Adipogenic (Magnification: 4x objective) 
 
Figure 4.17: Chondrogenic (Magnification: 10x objective) 
 
Figure 4.18: Osteogenic (Magnification: 10x objective) 
 
 
 
 
 
4.3.3 Cryoprotectant: 1% EBN+99% FBS 
Figure 4.19 and 4.20 shows the morphology for cells preserved in 1% EBN+99% FBS at a 
magnification of 4x and 10x objective, before staining.   
I. Before Staining 
          
Figure 4.19: Stem Cells Preserved in 1% EBN+99% FBS (Magnification: 4x objective) 
 
Figure 4.20: Stem Cells Preserved in 1% EBN+99% FBS (Magnification: 10x objective) 
 
 
 
 
 
 
 
 
 
 
Figure 4.21, 4.22 and 4.23 shows cells stained with the respective stains for the 
differentiation assay for cells preserved in 1%EBN+99% FBS. 
II. After Staining 
 
Figure 4.21: Adipogenic (Magnification: 4x objective) 
 
Figure 4.22: Chondrogenic (Magnification: 10x objective) 
 
Figure 4.23: Osteogenic (Magnification: 10x objective) 
 
 
 
 
 
4.4 Surface Area 
Table 4.5, 4.6 and 4.7 shows the percentage of surface area of adipogenesis, 
chondrogenesis and osteogenesis for cells preserved in the 10% DMSO+90% FBS, 5% 
DMSO+1% EBN+94% FBS and 1% EBN+99% FBS respectively. 
Table 4.5: Percentage of Surface Area of Cells Preserved in 10% DMSO+90% FBS  
Percentage of Surface Area of 10% DMSO+90% FBS (%) 
 
Adipogenesis Chondrogenesis Osteogenesis 
8.09 42.04 5.53 
17.73 60.19 9.22 
19.17 66.17 7.63 
Mean  15.00 56.13 7.46 
Standard Deviation 6.02 12.57 1.85 
Standard Error 3.48 7.26 1.07 
 
Table 4.6: Percentage of Surface Area of Cells Preserved in 5% DMSO+1% EBN+94% 
FBS 
Percentage of Surface Area of 5% DMSO+1% EBN+94% FBS (%) 
 
Adipogenesis Chondrogenesis Osteogenesis 
15.85 44.03 6.63 
19.91 50.43 7.34 
17.92 40.76 6.29 
Mean  17.89 45.07 6.75 
Standard Deviation 2.03 4.92 0.54 
Standard Error 1.17 2.84 0.31 
 
Table 4.7: Percentage of Surface Area of Cells Preserved in 1% EBN+99% FBS 
Percentage of surface area of 1% EBN+99% FBS (%) 
 
Adipogenesis Chondrogenesis Osteogenesis 
5.25 33.26 6.36 
7.77 32.00 7.05 
10.45 41.70 6.08 
Mean 7.82 35.65 6.50 
Standard Deviation 2.60 5.27 0.50 
Standard Error 1.50 3.05 0.29 
 
 
 
 
Figure 4.24 shows the comparison between the cryoprotectant for the percentage of surface 
area (using the mean value) for all the three lineages.  
 
 
 
 
 
 
 
 
 
 
Figure 4.24: Percentage of Surface Area for the Respective Differentiated Lineages versus 
Cryoprotectant 
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Adipogenesis: There is a significant difference (P<0.05) which is indicated by 
* between the groups of the cryoprotectant. 
Chondrogenesis:  There is a significant difference (P<0.05) which is indicated 
by * * between the groups of the cryoprotectant. 
Osteogenesis:  There is no significant difference (P>0.05) between all the 
three groups of the cryoprotectant. 
 
 
 
 
 
 
CHAPTER V 
 
DISCUSSION 
 
Based on Figure 4.1, the cells preserved in 10% DMSO+90% FBS has exhibited the highest 
percentage of cell viability with a mean of 91.33%. Generally, when a tissue or cells is 
subjected to a low temperature, ice crystals will be eventually formed. These crystals may 
disrupt the cell membrane leading to death of the cell and hence reducing cell viability. 
Therefore, according to (Ozkavukcu & Erdemli, 2002), a cryoprotectant is used to protect 
cells from mechanical and physical stress and also reduces the cellular damage by reducing 
the formation of ice crystals. Since, the cells preserved in 1% EBN+99% FBS had the 
lowest percentage of cell viability with a mean of 60.59%, hence it can be concluded that 
EBN perhaps does not have the mechanism to protect cells from mechanical and physical 
stress unlike DMSO. Research has concluded that extracellular cryoprotectant is not as 
efficient as the intracellular cryoprotectant (Motta et al., 2014). DMSO is an example of 
intracellular cryoprotectant which has its own mechanism to protect the cells. Perhaps EBN 
does not have the mechanism unlike DMSO to protect the cells. Hence, the viability of cells 
is low. Based on the One-way ANOVA shown in Appendix A, there is a significant 
difference (P<0.05) between all the three groups of cryoprotectant tested. 
Based on Figure 4.3 and 4.5, the growth curve shows a continuous increase in the 
number of cell for the cells preserved in both 10% DMSO+90% FBS and 5% DMSO+1% 
EBN+94%FBS from Day 1 to Day 14 of the resazurin reduction test. Based on Table 4.4, 
 
 
the cells preserved in 1% EBN+99% FBS had relatively lower number of cells as compared 
to the cells preserved in 10% DMSO+90% FBS and 5% DMSO+1% EBN+94%FBS. The 
number of cells for cells preserved in 1% EBN+99% FBS for Day 1, 10 and 14 are as 
follows: 36 800, 58 700 and 30 025. This further confirms the cell viability assay. Since the 
percentage of cell viability for the cells preserved in 1% EBN+99% FBS was initially low, 
therefore, this indicates a low number of cells in the culture and hence resulting in a lower 
proliferation rate. According to (Kong et al., 1987), EBN was proven to show an epidermal 
growth factor (EGF)-like activity which functions to induce cell division, tissue growth, 
cellular regeneration and cell-mediated immunity. It also contains glycoprotein which is 
responsible for promoting cell growth and gives them the ability to proliferate. According 
to (Roh et al., 2011), EBN strongly promotes proliferation of human adipose derived stem 
cells. However, these claims were not reflected on the results. Based on observation on the 
research papers above, all these studies were carried out in in vitro cell culture. Hence, it 
can be concluded that EBN promotes proliferation when it is in the in vitro cell culture 
environment whereas EBN as a cryoprotectant, it does not support the proliferation of the 
human adipose derived stem cells. Based on Figure 4.8, on Day 3, there is a significant 
difference (P<0.05) between 10% DMSO+90% FBS with 5% DMSO+1% EBN+94%FBS 
and 10% DMSO+90% FBS with 1% EBN+99% FBS. On Day 10, there is no significant 
difference (P>0.05) between all the three groups of cryoprotectant. Whereas on Day 14, 
there is a significant difference (P<0.05) between all the three groups of cryoprotectant 
tested.  
Based on Figure 4.24, the average percentage of surface area for adipogenic, 
chondrogenic and osteogenic lineage for the cells preserved in 1% EBN+99% FBS are 
relatively lower as compared to the cells preserved in 5% DMSO+1% EBN+94% FBS and 
 
 
10% DMSO+99% FBS. The average percentage of surface area for adipogenic, 
chondrogenic and osteogenic for cells preserved in 1% EBN+99% FBS are as follows: 
7.82%, 35.65% and 6.50% respectively. Some of the studies that are related  to the lineages 
studied and EBN extracts are as follows: according to (Chua et al., 2013), EBN extracts can 
act as a chondro-protective agent for human chondrocytes. Studies have also shown that 
rats’ bone strength and skin thickness were increased when administered with EBN extract 
(Matsukawa et al., 2011). Both these research papers have shown good results that were not 
reflected in the result of this research. Based on observation, again, these papers were 
carried out in in vitro cell culture. Hence, it can be concluded that EBN can support 
differentiation when it is in an in vitro cell culture environment. In terms of cryoprotectant, 
once the cells are thawed and cultured back, EBN does not support differentiation. 
Therefore, resulting in poor results. In conclusion, this confirms the statement earlier that 
EBN can promote proliferation and differentiation when it is in an in vitro cell culture but 
as a cryoprotectant it fails to exhibit the same results. Based on Figure 4.24, there is no 
significant difference (P>0.05) between all the three groups of cryoprotectant for 
osteogenic lineage. There is a significant difference (P<0.05) seen for both adipogenic and 
chondrogenic lineage. 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER VI 
 
CONCLUSION 
 
Based on the results for the following tests; cell viability test, resazurin reduction test and 
differentiation assay, it can be concluded that the human adipose derived stem cells 
preserved in 10% DMSO+99%FBS had exhibited a higher result as compared to cells 
preserved in 5% DMSO+1% EBN+94%FBS and 1% EBN+99% FBS. Hence making 
DMSO still a good and superior cryoprotective agent. DMSO on its own can support the 
growth of the cells which can be seen in 10% DMSO+99% FBS and does not require the 
presence of EBN. Therefore, it can be concluded that EBN cannot act as a cryoprotective 
agent. EBN is better to be used in in vitro cell culture experiments instead of it as a 
cryoprotective agent. There has been no study done on EBN as a cryoprotective agent 
which is the main limitation of this study. DMSO is known to cause toxicity to cells. The 
ability of DMSO to induce non lamellar structures in phospholipids and to enhance 
membrane permeability may also damage biological membrane at physiological 
temperature. Moreover, DMSO also has the ability to induce cell differentiation indicates 
that it might exert an influence at the genetic regulation level (Yu & Quinn, 1994). Some of 
the suggestions for future studies are as follows: to study on higher percentage of EBN 
extracts with lower concentration of DMSO on the human adipose derived stem cells, to 
study EBN extracts with other cryoprotective agents (e.g. trehalose) and also to evaluate the 
biosafety of the EBN extracts to be used on human adipose derived stem cells. Any positive 
 
 
results from these studies can introduce a natural cryoprotectant for cryopreservation of 
stem cells which will limit the usage of DMSO on whole, hence, reducing toxicity of 
DMSO to the cells.  
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APPENDIX A 
 
Statistical Analysis for Cell Viability Test 
One-way ANOVA  
Anova: Single Factor 
      
       SUMMARY 
      Groups Count Sum Average Variance 
  10% DMSO+90% FBS  6 548.00 91.33 21.68 
  5% DMSO+1% EBN+94% FBS  6 484.90 80.82 22.45 
  1% EBN+99% FBS 6 363.57 60.60 145.02 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 2928.81 2 1464.41 23.23 0.00 3.68 
Within Groups 945.72 15 63.05 
   
       Total 3874.53 17 
    
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX B 
Statistical Analysis for Resazurin Test 
(a) One-Way ANOVA for Day 3 Resazurin Test for the Respective Cryoprotectant 
Anova: Single Factor 
    
       SUMMARY 
     Groups Count Sum Average Variance 
  1% EBN+99% FBS 7.00 130.80 16.35 1.10 
  5% DMSO+1% EBN+94% FBS 7.00 111.86 15.98 1.45 
  10% DMSO+90% FBS 7.00 176.42 25.20 6.91 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 389.31 2.00 194.65 63.93 0.00 3.52 
Within Groups 57.86 19.00 3.05 
   
       Total 447.16 21.00 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) One-way ANOVA with post hoc t test for Day 3 Resazurin Test for the Respective 
Cryoprotectant 
I. Between 1% EBN+99% FBS and 5% DMSO+1% EBN+94% FBS  
t-Test: Two-Sample Assuming Equal Variances 
 
     1% EBN+99%FBS 5% DMSO+1% EBN+94% FBS 
Mean 16.35 15.98 
Variance 1.10 1.45 
Observations 7.00 7.00 
Pooled Variance 1.26 
 Hypothesized Mean Difference 0.00 
 df 13.00 
 t Stat 0.64 
 P(T<=t) one-tail 0.27 
 t Critical one-tail 1.77 
 P(T<=t) two-tail 0.54 
 t Critical two-tail 2.16 
  
 
II. Between 1% EBN+99% FBS and 10% DMSO+90% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     1% EBN+99%FBS 10% DMSO+90% FBS 
Mean 16.35 25.20 
Variance 1.10 6.91 
Observations 7.00 7.00 
Pooled Variance 3.78 
 Hypothesized Mean Difference 0.00 
 df 13.00 
 t Stat -8.80 
 P(T<=t) one-tail 0.00 
 t Critical one-tail 1.77 
 P(T<=t) two-tail 0.00 
 t Critical two-tail 2.16 
  
 
 
 
 
 
 
 
 
III. Between 5% DMSO+1% EBN+94% FBS and 10% DMSO+90% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     5% DMSO+1% EBN+94% FBS 10% DMSO+90% FBS 
Mean 15.98 25.20 
Variance 1.45 6.91 
Observations 7.00 7.00 
Pooled Variance 4.18 
 Hypothesized Mean Difference 0.00 
 df 12.00 
 t Stat -8.44 
 P(T<=t) one-tail 0.00 
 t Critical one-tail 1.78 
 P(T<=t) two-tail 0.00 
 t Critical two-tail 2.18 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) One-Way ANOVA for Day 10 Resazurin Test for the Respective Cryoprotectant 
Anova: Single Factor 
      
       SUMMARY 
      Groups Count Sum Average Variance 
  10% DMSO+90% FBS 7.00 198.86 28.41 26.45 
  5% DMSO+1% EBN+94% FBS 7.00 220.26 31.47 9.15 
  1% EBN+99% FBS 7.00 187.86 23.48 219.90 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 244.82 2.00 122.41 1.33 0.29 3.52 
Within Groups 1752.94 19.00 92.26 
   
       Total 1997.75 21.00 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(d) One-way ANOVA with post hoc t test for Day 10 Resazurin Test for the Respective 
Cryoprotectant 
I. Between 10% DMSO+90% FBS and 5% DMSO+1% EBN+99% FBS  
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS 5% DMSO+1% EBN+94% FBS 
Mean 28.41 31.47 
Variance 26.45 9.15 
Observations 7.00 7.00 
Pooled Variance 17.80 
 Hypothesized Mean Difference 0.00 
 df 12.00 
 t Stat -1.36 
 P(T<=t) one-tail 0.10 
 t Critical one-tail 1.78 
 P(T<=t) two-tail 0.20 
 t Critical two-tail 2.18 
  
II. Between 10% DMSO+90% FBS and 1% EBN+99% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS        1% EBN+99% FBS 
Mean 28.41 23.48 
Variance 26.45 219.90 
Observations 7.00 7.00 
Pooled Variance 130.62 
 Hypothesized Mean Difference 0.00 
 df 13.00 
 t Stat 0.83 
 P(T<=t) one-tail 0.21 
 t Critical one-tail 1.77 
 P(T<=t) two-tail 0.42 
 t Critical two-tail 2.16 
  
 
 
 
 
 
 
 
 
III. Between 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     5% DMSO+1% EBN+94% FBS    1% EBN+99% FBS 
Mean 31.47 23.48 
Variance 9.15 219.90 
Observations 7.00 7.00 
Pooled Variance 122.63 
 Hypothesized Mean Difference 0.00 
 df 13.00 
 t Stat 1.39 
 P(T<=t) one-tail 0.09 
 t Critical one-tail 1.77 
 P(T<=t) two-tail 0.19 
 t Critical two-tail 2.16 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(e) One-Way ANOVA for Day 14 Resazurin Test for the Respective Cryoprotectant 
Anova: Single Factor 
     SUMMARY 
      Groups Count Sum Average Variance 
  10% DMSO+90% FBS 7.00 265.07 37.87 62.26 
  5% DMSO+1% EBN+94% FBS 7.00 315.81 45.12 13.39 
  1% EBN+99% FBS 7.00 96.06 12.01 5.22 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 4609.21 2.00 2304.60 89.29 0.00 3.52 
Within Groups 490.42 19.00 25.81 
   
       Total 5099.63 21.00 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(f) One-way ANOVA with post hoc t test for Day 14 Resazurin Test for the Respective 
Cryoprotectant 
I. Between 10% DMSO+90% FBS and 5% DMSO+1% EBN+99% FBS  
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS 5% DMSO+1% EBN+94% FBS 
Mean 37.87 45.12 
Variance 62.26 13.39 
Observations 7.00 7.00 
Pooled Variance 37.82 
 Hypothesized Mean Difference 0.00 
 df 12.00 
 t Stat -2.21 
 P(T<=t) one-tail 0.02 
 t Critical one-tail 1.78 
 P(T<=t) two-tail 0.05 
 t Critical two-tail 2.18 
  
II. Between 10% DMSO+90% FBS and 1% EBN+99% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS 1% EBN+99% FBS 
Mean 37.87 12.01 
Variance 62.26 5.22 
Observations 7.00 7.00 
Pooled Variance 31.55 
 Hypothesized Mean Difference 0.00 
 df 13.00 
 t Stat 8.90 
 P(T<=t) one-tail 0.00 
 t Critical one-tail 1.77 
 P(T<=t) two-tail 0.00 
 t Critical two-tail 2.16 
  
 
 
 
 
 
III. Between 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     5% DMSO+1% EBN+94% FBS 1% EBN+99% FBS 
Mean 45.12 12.01 
Variance 13.39 5.22 
Observations 7.00 7.00 
Pooled Variance 8.99 
 Hypothesized Mean Difference 0.00 
 df 13.00 
 t Stat 21.34 
 P(T<=t) one-tail 0.00 
 t Critical one-tail 1.77 
 P(T<=t) two-tail 0.00 
 t Critical two-tail 2.16 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX C 
Statistical Analysis for Surface Area of Differentiated Lineages 
(a) One-Way ANOVA for the Percentage of Surface area of Adipogenesis for the 
Respective Cryoprotectant 
Anova: Single Factor 
    
       SUMMARY 
     Groups Count Sum Average Variance 
  10% DMSO+90% FBS 3 44.99 15.00 36.30 
  5% DMSO+1% EBN+94% FBS 3 53.68 17.90 4.12 
  1% EBN+99% FBS 3 23.47 7.82 6.76 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 161.25 2 80.63 5.13 0.05 5.14 
Within Groups 94.36 6 15.73 
   
       Total 255.61 8 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) One-way ANOVA with post hoc t test for Percentage of Surface area of Adipogenesis 
for the Respective Cryoprotectant 
I. Between 10% DMSO+90% FBS and 5% DMSO+1% EBN+94% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS 5% DMSO+1% EBN+94% FBS  
Mean 15.00 17.89 
Variance 36.29 4.12 
Observations 3.00 3.00 
Pooled Variance 20.21 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat -0.79 
 P(T<=t) one-tail 0.24 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.47 
 t Critical two-tail 2.78 
  
 
II. Between 10% DMSO+90% FBS and 1% EBN+99% FBS 
 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS      1% EBN+99% FBS  
Mean 15.00 7.82 
Variance 36.29 6.76 
Observations 3.00 3.00 
Pooled Variance 21.53 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 1.89 
 P(T<=t) one-tail 0.07 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.13 
 t Critical two-tail 2.78 
  
 
 
 
 
 
 
 
 
III. Between 5% DMSO+1% EBN and 1% EBN+99% FBS 
 
t-Test: Two-Sample Assuming Equal Variances 
 
     5% DMSO + 1% EBN+94% FBS  1% EBN+99% FBS  
Mean 17.89 7.82 
Variance 4.12 6.76 
Observations 3.00 3.00 
Pooled Variance 5.44 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 5.29 
 P(T<=t) one-tail 0.00 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.01 
 t Critical two-tail 2.78 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) One-Way ANOVA for the Percentage of Surface area of Chondrogenesis for the 
Respective Cryoprotectant 
Anova: Single Factor 
    
       SUMMARY 
     Groups Count Sum Average Variance 
  10% DMSO+90% FBS 3 168.4 56.13 157.91 
  5% DMSO+1% EBN+94% FBS 3 135.22 45.07 24.19 
  1% EBN+99% FBS 3 106.96 35.65 27.82 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 630.49 2 315.25 4.51 0.06 5.14 
Within Groups 419.84 6 69.97 
   
       Total 1050.33 8 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(d) One-way ANOVA with post hoc t test for Percentage of Surface area of 
Chondrogenesis for the Respective Cryoprotectant 
I. Between 10% DMSO+90% FBS and 5% DMSO+1% EBN+94% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS  5% DMSO+1% EBN+94% FBS  
Mean 56.13 45.07 
Variance 157.91 24.19 
Observations 3.00 3.00 
Pooled Variance 91.05 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 1.42 
 P(T<=t) one-tail 0.11 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.23 
 t Critical two-tail 2.78 
  
 
II. Between 10% DMSO+90% FBS and 1% EBN+99% FBS 
 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS       1% EBN+99% FBS 
Mean 56.13 35.65 
Variance 157.91 27.82 
Observations 3.00 3.00 
Pooled Variance 92.86 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 2.60 
 P(T<=t) one-tail 0.03 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.06 
 t Critical two-tail 2.78 
  
 
 
 
 
 
 
 
 
III. Between 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS 
 
t-Test: Two-Sample Assuming Equal Variances 
 
     5% DMSO+1% EBN+94% FBS  1% EBN+99% FBS  
Mean 45.07 35.65 
Variance 24.19 27.82 
Observations 3.00 3.00 
Pooled Variance 26.01 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 2.26 
 P(T<=t) one-tail 0.04 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.09 
 t Critical two-tail 2.78 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(e) One-Way ANOVA for the Percentage of Surface area of Osteogenesis for the 
Respective Cryoprotectant 
Anova: Single Factor 
    
       SUMMARY 
     Groups Count Sum Average Variance 
  10% DMSO+90% FBS 3 22.38 7.46 3.43 
  5% DMSO+1% EBN+94% FBS 3 20.26 6.75 0.29 
  1% EBN+99% FBS 3 19.49 6.50 0.25 
  
       
       ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 1.49 2 0.75 0.57 0.60 5.14 
Within Groups 7.92 6 1.32 
   
       Total 9.42 8 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(f) One-way ANOVA with post hoc t test for Percentage of Surface area of Osteogenesis 
for the Respective Cryoprotectant 
I. Between 10% DMSO+90% FBS and 5% DMSO+1% EBN+94% FBS 
 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS  5% DMSO+1% EBN+94% FBS  
Mean 7.46 6.75 
Variance 3.43 0.29 
Observations 3.00 3.00 
Pooled Variance 1.86 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 0.64 
 P(T<=t) one-tail 0.28 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.56 
 t Critical two-tail 2.78 
  
 
II. Between 10% DMSO+90% FBS and 1% EBN+99% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     10% DMSO+90% FBS   1% EBN+99% FBS 
Mean 7.46 6.50 
Variance 3.43 0.25 
Observations 3.00 3.00 
Pooled Variance 1.84 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 0.87 
 P(T<=t) one-tail 0.22 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.43 
 t Critical two-tail 2.78 
  
 
 
 
 
 
 
 
III. Between 5% DMSO+1% EBN+94% FBS and 1% EBN+99% FBS 
t-Test: Two-Sample Assuming Equal Variances 
 
     5% DMSO+1% EBN+94% FBS  1% EBN+99% FBS  
Mean 6.75 6.50 
Variance 0.29 0.25 
Observations 3.00 3.00 
Pooled Variance 0.27 
 Hypothesized Mean Difference 0.00 
 df 4.00 
 t Stat 0.61 
 P(T<=t) one-tail 0.29 
 t Critical one-tail 2.13 
 P(T<=t) two-tail 0.58 
 t Critical two-tail 2.78 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
